Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety

Biopharma

CompuMark CompuMark
Blog October 7, 2019
Integrated delivery networks and their growing influence on regional healthcare in the United States
Blog October 7, 2019
Massachusetts Enhances Ability to Negotiate Medicaid Drug Rebates
Blog October 4, 2019
Implications of updated WHO Essential Medicines List
Report: Biopharma licensing eclipsed $33 billion in Q2 2019 Report: Biopharma licensing eclipsed $33 billion in Q2 2019
Blog October 4, 2019
Report: Biopharma licensing eclipsed $33 billion in Q2 2019
Blog October 3, 2019
Results from PARP Inhibitor Trials Point to Drastic Changes for Ovarian Cancer Management
Blog October 3, 2019
Malignant Melanoma – Is Cure a Possibility?
Blog October 1, 2019
UnitedHealth Prefers Oncology Biosimilars Over Roche’s Herceptin, Avastin
Blog September 27, 2019
Limited distribution drugs 101
Blog September 20, 2019
Tracing the Treatment Journey Using Real-World Data
Dialog Solutions ISO 9001:2015 Certified Dialog Solutions ISO 9001:2015 Certified
Blog September 18, 2019
Dialog Solutions ISO 9001:2015 Certified